Dog /
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog)
7,541 adverse event reports submitted to the FDA
Important: Adverse event reports are voluntarily submitted and do not prove causation. Consult your veterinarian for medical decisions about your dog.
7,541
Total Reports
268
Deaths Reported
360.0%
Death Rate
4.8 yr
Avg Age at Report
Average weight at time of report: 20.5 kg (45.2 lbs)
Top Reported Reactions
Vomiting 1,301
Lack of efficacy (endoparasite) - heartworm 1,071
INEFFECTIVE, HEARTWORM LARVAE 550
Lethargy (see also Central nervous system depression in 'Neurological') 540
Diarrhoea 440
Emesis 425
Lack of efficacy (endoparasite) - hookworm 412
Lack of efficacy - NOS 354
Lack of efficacy (ectoparasite) - flea 316
Seizure NOS 261
Anorexia 198
Lack of efficacy (ectoparasite) - tick NOS 189
Digestive tract disorder NOS 186
Lack of efficacy (endoparasite) - roundworm NOS 175
Ataxia 168
Most Referenced Drugs
Milbemycin Oxime + Spinosad 1,329
Ivermectin + Pyrantel As Pamoate Salt 1,106
Pyrantel Pamoate;Sarolaner 557
Afoxolaner 504
Milbemycin Oxime + Praziquantel 491
Moxidectin 452
Spinosad 298
Fluralaner Chew Tablets 254
Fluralaner 13.64% 12-Week Chew 234
Bedinvetmab 227
Trilostane 192
Carprofen 171
Oclacitinib Maleate 129
Sarolaner 127
Lotilaner 120
Outcome Breakdown
Outcome Unknown
2,535 (35.3%)
Ongoing
1,998 (27.8%)
Recovered/Normal
1,970 (27.5%)
Recovered with Sequela
405 (5.6%)
Died
136 (1.9%)
Euthanized
132 (1.8%)
Gender Distribution
Female 3,957 (52.5%)
Male 3,458 (45.9%)
Unknown 99 (1.3%)
Mixed 27 (0.4%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2010 | 189 | |
| 2011 | 248 | |
| 2012 | 326 | |
| 2013 | 360 | |
| 2014 | 393 | |
| 2015 | 489 | |
| 2016 | 486 | |
| 2017 | 509 | |
| 2018 | 458 | |
| 2019 | 562 | |
| 2020 | 578 | |
| 2021 | 567 | |
| 2022 | 567 | |
| 2023 | 629 | |
| 2024 | 706 | |
| 2025 | 474 | |
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Rank #26 by report volume. Data reflects voluntary submissions and may not represent actual incidence rates.